Gainers
- Akanda AKAN shares increased by 33.5% to $0.28 during Tuesday's after-market session. Trading volume for this security closed at 442.1K, accounting for 67.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $9.6 million.
- Coeptis Therapeutics COEP stock rose 15.6% to $2.0. The market value of their outstanding shares is at $10.2 million.
- Nektar Therapeutics NKTR stock moved upwards by 12.71% to $3.28. The company's market cap stands at $616.4 million.
- Viridian Therapeutics VRDN shares rose 9.26% to $25.0. The market value of their outstanding shares is at $1.0 billion.
- VistaGen Therapeutics VTGN shares increased by 7.97% to $0.15. Trading volume for this security closed at 295.7K, accounting for 5.0% of its average full-day volume over the last 100 days. The company's market cap stands at $30.8 million.
- China SXT Pharmaceuticals SXTC shares moved upwards by 7.62% to $0.69. The company's market cap stands at $1.8 million.
Losers
- X4 Pharmaceuticals XFOR shares fell 10.8% to $1.65 during Tuesday's after-market session. This security traded at a volume of 954.9K shares come close, making up 115.3% of its average volume over the last 100 days. The company's market cap stands at $114.2 million.
- Alzamend Neuro ALZN shares decreased by 7.63% to $1.09. The company's market cap stands at $105.0 million.
- Ontrak OTRK stock decreased by 5.71% to $0.38. The company's market cap stands at $10.2 million.
- Redhill Biopharma RDHL shares declined by 5.49% to $0.33. Today's trading volume for this security ended up closing at 388.1K shares, which is 13.3 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $21.2 million. The company's, Q3 earnings came out today.
- Otonomy OTIC stock fell 5.38% to $0.22. Otonomy's trading volume hit 21.0 million shares by close, accounting for 700.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $12.3 million.
- Applied Genetic Techs AGTC shares declined by 4.81% to $0.37. The market value of their outstanding shares is at $25.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in